Biology:Bacterial capsule

From HandWiki
Short description: Polysaccharide layer that lies outside the cell envelope in many bacteria
The outer red layer in this diagram is the capsule, which is distinct from the cell envelope. This bacterium is gram-positive, as its cell envelope comprises a single cell membrane (orange) and a thick peptidoglycan-containing cell wall (purple).

The bacterial capsule is a large structure common to many bacteria.[1] It is a polysaccharide layer that lies outside the cell envelope, and is thus deemed part of the outer envelope of a bacterial cell. It is a well-organized layer, not easily washed off, and it can be the cause of various diseases.[2][3]

The capsule—which can be found in both gram negative and gram-positive bacteria—is different from the second lipid membrane – bacterial outer membrane, which contains lipopolysaccharides and lipoproteins and is found only in gram-negative bacteria. When the amorphous viscid secretion (that makes up the capsule) diffuses into the surrounding medium and remains as a loose undemarcated secretion, it is known as a slime layer. Capsule and slime layer are sometimes summarized under the term glycocalyx.

A bacterial capsule has a semi-rigid border that follows the contour of the cell. The capsule excludes India Ink when dyed. A slime layer is a non-rigid matrix that is easily deformed and is not able to exclude India Ink. Biofilms are composed of many cells and their outer barriers. The primary functions of both capsules and slime layers are for protection and adhesion.

Composition

Most bacterial capsules are composed of polysaccharide,[4] but some species use other materials, such as poly-D-glutamic acid in Bacillus anthracis. Because most capsules are so tightly packed, they are difficult to stain because most standard stains cannot penetrate the capsule. To visualize encapsulated bacteria using a microscope, a sample is treated with a dark stain, such as India ink. The structure of the capsule prevents the stain from penetrating the cell. When viewed, bacterial capsules appear as a bright halo around the cell on a dark background.[5]

Function

The bacterial capsule serves as a shield, giving protection from toxins, and from drying out. Capsules allow adhesion to surfaces and help enable the bacteria to evade the host immune system.[6] The water content in the capsule gives the protection against drying out. The capsule is considered a virulence factor because it enhances the ability of bacteria to cause disease (e.g. prevents phagocytosis). The capsule can protect cells from engulfment by eukaryotic cells, such as macrophages.[7] A capsule-specific antibody may be required for phagocytosis to occur. They also exclude bacterial viruses and most hydrophobic toxic materials such as detergents.[citation needed] Immunity to one capsule type does not result in immunity to the other types. Capsules also help cells adhere to surfaces. As a group where the capsule is present they are known as polysaccharide encapsulated bacteria or encapsulated bacteria.[8]

Diversity

The capsule is found most commonly among gram-negative bacteria:

However, some gram-positive bacteria may also have a capsule:

The yeast Cryptococcus neoformans,[23] though not a bacterium, has a similar capsule.[24][25]

Capsules too small to be seen with an ordinary microscope, such as the M protein of Streptococcus pyogenes, are called microcapsules.

Demonstration of capsule

  1. India ink staining: the capsule appears as a clear halo around the bacterium as the ink can't penetrate the capsule.[26]:87
  2. Maneval's capsule stain: the capsule appears as a clear halo between the pink-stained bacterium and the bluish-grey stained background. The background stain is the acidic stain Congo red (which changes color to bluish-grey due to the pH), and the pink stain is fuchsine.
  3. Serological methods: Capsular material is antigenic and can be demonstrated by mixing it with a specific anticapsular serum. When examined under the microscope, the capsule appears 'swollen' due to an increase in its refractivity. This phenomenon is the basis of quellung reaction.

Use in vaccination

Vaccination using capsular material is effective against some organisms (e.g., H. influenzae type b,[27][28] S. pneumoniae, and N. meningitidis[29]). However, polysaccharides are not highly antigenic, especially in children, so many capsular vaccines contain polysaccharides conjugated with protein carriers, such as the tetanus toxoid or diphtheria toxoid. This stimulates a much more robust immune response.[30]

See also

References

  1. Peterson, Johnny W. (1996). Bacterial Pathogenesis. University of Texas Medical Branch at Galveston. ISBN 9780963117212. https://www.ncbi.nlm.nih.gov/books/NBK8526/. Retrieved 17 January 2018. 
  2. "Inactivation of microorganisms by low-frequency high-power ultrasound: 1. Effect of growth phase and capsule properties of the bacteria". Ultrasonics Sonochemistry 21 (1): 446–53. January 2014. doi:10.1016/j.ultsonch.2013.06.006. PMID 23835398. 
  3. "Streptococcus pneumoniae capsule determines disease severity in experimental pneumococcal meningitis". Open Biology 6 (3): 150269. March 2016. doi:10.1098/rsob.150269. PMID 27009189. 
  4. "bacterial capsule" at Dorland's Medical Dictionary
  5. "Basteria: Capsules and Slime Layers". Encyclopædia Britannica. http://www.britannica.com/EBchecked/topic/48203/bacteria/39338/Capsules-and-slime-layers. 
  6. "The bacterial capsule is a gatekeeper for mobile DNA". PLOS Biol 19 (7): e3001308. July 2021. doi:10.1371/journal.pbio.3001308. PMID 34228713. 
  7. "The capsule of Mycobacterium tuberculosis and its implications for pathogenicity". Tubercle and Lung Disease 79 (3): 153–69. 1999. doi:10.1054/tuld.1998.0200. PMID 10656114. 
  8. "Polyosides (encapsulated bacteria)". Comptes Rendus de l'Académie des Sciences, Série III 322 (11): 925–32. November 1999. doi:10.1016/s0764-4469(00)87188-7. PMID 10646085. Bibcode1999CRASG.322..925L. 
  9. "Meningococcal meningitis". Textbookofbacteriology.net. http://textbookofbacteriology.net/themicrobialworld/meningitis.html. 
  10. "Molecular characterization of invasive capsule null Neisseria meningitidis in South Africa". BMC Microbiology 17 (1): 40. February 2017. doi:10.1186/s12866-017-0942-5. PMID 28222677. 
  11. "Description and nomenclature of Neisseria meningitidis capsule locus" (in en-us). Emerging Infectious Diseases 19 (4): 566–73. April 2013. doi:10.3201/eid1904.111799. PMID 23628376. 
  12. "Role of bacterial capsule in local and systemic inflammatory responses of mice during pulmonary infection with Klebsiella pneumoniae". Journal of Medical Microbiology 49 (11): 1003–10. November 2000. doi:10.1099/0022-1317-49-11-1003. PMID 11073154. 
  13. "Klebsiella pneumoniae Defined by density-TraDISort". mBio 9 (6). November 2018. doi:10.1128/mBio.01863-18. PMID 30459193. 
  14. "Capsule and fimbria interaction in Klebsiella pneumoniae". Infection and Immunity 73 (8): 4626–33. August 2005. doi:10.1128/IAI.73.8.4626-4633.2005. PMID 16040975. 
  15. "Two variants among Haemophilus influenzae serotype b strains with distinct bcs4, hcsA and hcsB genes display differences in expression of the polysaccharide capsule". BMC Microbiology 8 (1): 35. February 2008. doi:10.1186/1471-2180-8-35. PMID 18298818. 
  16. "The algR gene, which regulates mucoidy in Pseudomonas aeruginosa, belongs to a class of environmentally responsive genes". Journal of Bacteriology 171 (3): 1278–83. March 1989. doi:10.1128/jb.171.3.1278-1283.1989. PMID 2493441. 
  17. "Salmonella produces an O-antigen capsule regulated by AgfD and important for environmental persistence". Journal of Bacteriology 188 (22): 7722–30. November 2006. doi:10.1128/JB.00809-06. PMID 17079680. 
  18. Kenyon, Johanna J.; Hall, Ruth M. (2013-04-16). de Crécy-Lagard, Valerie. ed. "Variation in the Complex Carbohydrate Biosynthesis Loci of Acinetobacter baumannii Genomes" (in en). PLOS ONE 8 (4): e62160. doi:10.1371/journal.pone.0062160. ISSN 1932-6203. PMID 23614028. Bibcode2013PLoSO...862160K. 
  19. Singh, Jennifer K.; Adams, Felise G.; Brown, Melissa H. (2019-01-09). "Diversity and Function of Capsular Polysaccharide in Acinetobacter baumannii". Frontiers in Microbiology 9: 3301. doi:10.3389/fmicb.2018.03301. ISSN 1664-302X. PMID 30687280. 
  20. "Capsule Prolongs Survival of Streptococcus pneumoniae during Starvation". Infection and Immunity 86 (3). March 2018. doi:10.1128/IAI.00802-17. PMID 29311231. 
  21. "The Streptococcus pneumoniae capsule inhibits complement activity and neutrophil phagocytosis by multiple mechanisms". Infection and Immunity 78 (2): 704–15. February 2010. doi:10.1128/IAI.00881-09. PMID 19948837. 
  22. Rao, Shreesha; Chen, Mei‐Yun; Sudpraseart, Chiranan; Lin, Peiry; Yoshida, Terutoyo; Wang, Pei‐Chi; Chen, Shih‐Chu (2022). "Genotyping and phenotyping of Lactococcus garvieae isolates from fish by pulse‐field gel electrophoresis (PFGE) and electron microscopy indicate geographical and capsular variations". Journal of Fish Diseases 45 (6): 771–781. doi:10.1111/jfd.13601. PMID 35235703. https://onlinelibrary.wiley.com/doi/10.1111/jfd.13601. 
  23. "The Cryptococcus neoformans capsule: a sword and a shield". Clinical Microbiology Reviews 25 (3): 387–408. July 2012. doi:10.1128/CMR.00001-12. PMID 22763631. 
  24. "Molecular architecture of the Cryptococcus neoformans capsule". Molecular Microbiology 52 (1): 13–24. April 2004. doi:10.1111/j.1365-2958.2003.03957.x. PMID 15049807. 
  25. "Cryptococcus neoformans". Virulence 10 (1): 822–831. December 2019. doi:10.1080/21505594.2018.1431087. PMID 29436899. 
  26. Rudolph, K.W.E. (1996). "Chapter 3: Pseudomonas synringae pathovars". Pathogenesis & Host Specificity in Plant Diseases. 1: Prokaryotes (1st ed.). Amsterdam: Elsevier Science. ISBN 978-0-08-098473-5. 
  27. "Capsule gene analysis of invasive Haemophilus influenzae: accuracy of serotyping and prevalence of IS1016 among nontypeable isolates". Journal of Clinical Microbiology 45 (10): 3230–8. October 2007. doi:10.1128/JCM.00794-07. PMID 17699642. 
  28. "In Silico Serotyping of the Haemophilus influenzae Capsule Locus". Journal of Clinical Microbiology 57 (6). June 2019. doi:10.1128/JCM.00190-19. PMID 30944197. 
  29. "Regulation of capsule in Neisseria meningitidis". Critical Reviews in Microbiology 42 (5): 759–72. September 2016. doi:10.3109/1040841X.2015.1022507. PMID 26089023. 
  30. "Conjugate vaccines". Clinical and Experimental Immunology 119 (1): 1–3. January 2000. doi:10.1046/j.1365-2249.2000.01109.x. PMID 10671089.